Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.55    0.10 (0.61%)
Bid:
16.40
Ask:
16.55
Spread: 0.15 (0.915%)
Market Cap: £132.65m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Trading Update

1 Oct 2012 13:14

RNS Number : 6068N
Allocate Software PLC
01 October 2012
 



 

1 October 2012

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Trading Update

 

Allocate Software, (AIM: ALL), the leading provider of workforce optimisation and corporate governance, risk & compliance software gives the following update on trading for the first three months of the current financial year ending 31 May 2013.

 

New licence sales have been lower than expected during the first quarter, which historically is the weakest period due to the summer slowdown, particularly in our UK healthcare business. This was as a result of delays in contracts closing, not competitive losses, and therefore the current pipeline for new business wins and licence renewals remains strong. The timing will have a knock-on effect on implementation and support revenues in the current quarter.

 

Progress in our growing portfolio of subscription-based product lines has been encouraging, with a number of these performing above management expectation, most notably our new Allocate Cloud service which we launched during the first quarter. It is however a function of the subscription model that the revenues from new business wins, recognised rateably over an extended period, will not significantly offset the impact of reduced licence and services revenues in the first half, though it does provide a more secure basis for the business in the longer term.

 

As a result of these factors and the changing business mix, the Board now expects that first half revenues will be lower than its original expectations, albeit broadly in line with the first half of the last financial year, and EBITDA will be below the prior year first half comparable.

 

Ian Bowles, Chief Executive, commented: "The Board continues to believe that the Company's new business pipeline and prospects remain strong, and will continue to drive the business towards meeting its financial targets for the full year. Whilst it is not possible to be certain that the first half revenue shortfall will be fully recouped in the second half, any resulting impact on profits will likely be mitigated by tight control over operating expenditure."

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade / Simon Willis /

Richard Thomas

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.Allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUAAURURARRAA
Date   Source Headline
20th Nov 20247:00 amRNS-RInvestor Presentation - Swiss Mining Institute
5th Nov 20247:00 amRNSTR-1 Notification of Major Holdings
30th Oct 20247:00 amRNSNotice of AGM
25th Oct 20247:00 amRNSSuccessful Completion of A$10m Equity Placing
24th Oct 20244:35 pmRNSA$9 million Equity Placing
24th Oct 20244:31 pmRNSQuarterly Activities and Cash Flow Report
8th Oct 20247:00 amRNSGrant of Mine Operating Permit
18th Sep 20247:00 amRNS2024 Annual Financial Report
12th Sep 20247:00 amRNSGrant of Ewoyaa Lithium Mining Project EPA Permit
16th Aug 20247:00 amRNSGrant of Performance Rights to Employees
30th Jul 20247:15 amRNSQuarterly Activities and Cash Flow Report
30th Jul 20247:00 amRNSNew Dog-Leg Target Delivers Increase to Ewoyaa MRE
12th Jul 20248:30 amRNSEwoyaa Lithium Project Update
10th Jul 20247:00 amRNSFatal Incident at the Ewoyaa Lithium Project
30th May 20247:00 amRNSField Work Underway at Senya Beraku Licence
15th May 20249:55 amRNSBoard Appointment - Replacement
15th May 20247:00 amRNSBoard Appointment
10th May 20247:00 amRNSAdmission to Trading on the Ghana Stock Exchange
7th May 20247:10 amRNSConference Attendance – CG Global Metals & Mining
7th May 20247:00 amRNSDog-Leg Delivers Further High-grade Intersections
2nd May 20247:00 amRNSApproval to List on the Ghana Stock Exchange
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.